Thought Leaders

Josh Abbott

Editor, BPI Insider

Bioprocess International

Udayanath Aich, Ph.D.

Associate Director

Bristol Myers Squibb

Dr Daniel Aili

Professor of Molecular Physics

Linköping University/ArgusEye

Cécile Brocard

Director Downstream Development, DevOps Austria

Boehringer Ingelheim RCV GmbH & Co KG

Michael Butler

Principal Investigator, Cell Technology

NIBRT

Imara Charles

VP, Process and Digital Excellence, Global Supply Chain

Bristol Meyers Squibb

CAPT James Coburn

Senior Advisor for Emerging Technologies

FDA

Steven Cramer, Ph.D.

Institute Professor, Isermann Department of Chemical and Biological Engineering

RPI

Tingting Cui, Ph.D.

Associate Principal Scientist

AstraZeneca

Kurtis Denny

Senior Engineer I, Cell Culture Development

Biogen

Wenjun Di

Senior Scientist

Ultragenyx Pharmaceutical Inc.

Jared Dopp, PhD

Scientist, Upstream Process Development

Bristol-Myers Squibb

Victoria Drake Carnein

Upstream Process Development Scientist I

Alexion AstraZeneca Rare Disease

Mark Duerkop

Chief Executive Officer

Novasign, Austria

Dawn Eriksen-Stapleton, PhD

Principal Scientist

Pfizer

Bin Fan, PhD

Director of Biologics

NGM Biopharmaceuticals

Jishna Ganguly

Expert Scientist

GSK

Dr Nathalie Gerassimov

Development Scientist

Macrogenics

Sabat Gonzalez-Serrano

Graduate Research Associate

The Ohio State University

Sanjeev Gupta

Sr. Vice President and Head Biosimilars

Ipca Laboratories

Dr Sarah Harcum

Professor

Clemson University

Dr Steve Harding

President

Advanced Process Combinatorics, Inc.

Christoph Herwig

Senior Scientific Advisor

Körber Pharma Austria GmbH, Austria

Hui-Lan Hu

Senior Scientist

AstraZeneca

Jonas Immel-Brown

Scientist - Technical Development

Biogen

Don Jarvis

President

GlycoBac, LLC

Marion Jenny

MSAT Senior Scientist (DSP)

MeiraGTx

Rebecca Jeppson

Scientist

Sanofi

Kalle Johnson

Senior Director

UPSIDE Foods

Mr Satish Kallappagoudar

Associate Principal Scientist

Merck

Thomas Kelly

Director, Cell Engineering & Analytical Sciences

Johnson & Johnson Innovative Medicine

Min Cheol Kim

Process Engineer IV

Sanofi

Maximilian Krippl

Head of Consulting

Novasign GmbH

Joseph Kwon

Associate Professor, Chemical Engineering

Texas A & M University

Ms Cynthia Lam

Technical Development Scientist

Genentech

Ken Lee

Senior Scientist

AstraZeneca

Abraham Lenhoff

Allan P. Colburn Professor

University of Delaware

Nathan Lewis

Associate Professor

University of California San Diego

Yi Li

Process Development Scientist

Amgen, Inc.

Marinna Madrid

Co-Founder & Chief Product Officer

Cellino

Juan Manuel Marin-Celis

Bio-Separations Scientist

Merck

Elizabeth Masterjohn

Scientist, Cell Line Development

Sanofi Genzyme

Mr Neil McCracken

Upstream Process Development Group Leader

Elanco

Stefano Menegatti

Associate Professor

North Carolina State University

Charles Mitchell

Senior Process Scientist, Cell Culture

Visterra Inc

Jeffrey Mocny

Vice President, Scientific Project Leader

Abzena

Nhu Nguyen

Scientist, Cell Line Development and Process Development

Aragen Bioscience Inc

Mr Wenqin Ni

Senior Principal Scientist

Pfizer

Sanjay Nilapwar, Ph.D.

Principal Scientist I, Purification Development, BioProcess Development, Operations Science & Technology – Biologics

Abbvie

Nikki Nogal, PhD

Senior Consultant, Biologics Product Development Specialist

Latham BioPharm Group

Kevin E. Noonan, Ph.D.

Partner

McDonnell Boehnen Hulbert & Berghoff LLP

Chase Orsello

Global Head, Bioprocess Development

Sanofi

Jianfa Ou

Principal Scientist, Biologics Development, Global Product Development and Supply

Bristol Myers Squibb

Joseph Pekny

Professor, Chemical Engineering

Purdue University

Dennis Pfaff

Investigator II

Novartis

Dale R.Mowrey

Associate Director of Material Science

Teva Pharmaceuticals

Vida Rahmatnejad

Upstream Process Development Scientist

Alexion

Irina Ramos, Ph.D

Director of Bioprocess Technology and Engineering

AstraZeneca

Mr Jesse Richter

Executive Director, Global Tech Ops - Tech Transfer and Validation

AstraZeneca

Frank Ritacco, PhD

Senior Director, Cell Culture Development

Regeneron

Qian Ruan, Ph.D

Senior Vice president of TechOps and Supply Chain

Arcturus Therapeutics

Eva Rubio-Marrero

Senior Scientist II

AbbVie

Dr Pitchai Sangan

Associate Director of Cell Line Development

Boston Institute of Biotechnology, LLC

Mr. Tillmann Schnierda

Director, Commercial Development, Mammalian

Lonza

Jason Souvaliotis

Associate Scientist, Biopharmaceutical Drug Substance Process Development

GSK

Dr. Nathan Stover

Researcher, Braatz Group

MIT

Danijel Svec

Senior Cell Line Development Associate & Project Team Leader

ExcellGene SA

Garima Thakur

Process Development Engineer III

Regeneron Pharmaceuticals

Nick Vecchiarello, Ph.D.,

Assistant Professor, Chemical Engineering

University of Virginia

Mr William Whitford

Founder

Oamaru BioSystems

Alex Williams

Senior Associate Scientist, Biologics Development, Global Product Development and Supply

Bristol-Myers Squibb

David Wood

Professor of Chemical and Biomolecular Engineering

Ohio State University

Elise Woodall

Automation Engineer

AstraZeneca

Hui Xiao

Senior Staff Scientist

Regeneron

Lihua Yang,PhD

Senior Principal Research Scientist

AbbVie

Winnie Yeung

Scientist

Gilead

Yuan Yuan

Sr Scientist, Cell Culture Development

Teva Pharmaceuticals

Mr Stephen Zano

Director, Early Research and Process Development

Sarepta Therapeutics

Mr Zheng Zhang

Head of Cell Line Development

BeiGene

Andrew Zydney, Ph.D.

Bayard D. Kunkle Chair, Chemical Engineering

Penn State University